A new biomarker has been discovered that makes it possible to identify women with uterine cancer who have a high risk of recurrence. Endometrial cancer of the uterus is the most common form of gynecologic cancer in Europe and North America. The treatment primarily consists of removing the uterus and in some cases offering chemotherapy if the risk of recurrence is deemed high.
No hay comentarios:
Publicar un comentario